Close Menu

Not So Easy

Elias Zerhouni, the former National Institutes of Health director who now heads up R&D at Sanofi-Aventis, has found that translational medicine is more difficult than he'd expected, reports the Wall Street Journal's Health Blog. Zerhouni, the Health Blog notes, pushed for better translational medicine. Upon joining Sanofi, "I thought the solution would be simple," Zerhouni said at a press event.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.